

Siamab Therapeutics is a biopharmaceutical company that develops therapies targeting abnormal carbohydrates found only on cancer cells.
| Headquarter | 90 Bridge Street Suite 100 Newton, MA United States of America |
|---|---|
| Website | www.siamab.com/ |
| Founding Date | 2006 |
| Tel | (800) 513-1569 |
| Company Status | Private |
Siamab Therapeutics competitors include Eureka Therapeutics and Surface Oncology. See below how Siamab Therapeutics compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.

No Recent Jobs found for Siamab Therapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

Candidates By Department
Product | 100% |
|---|
Candidates By Location
Newton | 100% |
|---|
What is Siamab Therapeutics address?
Siamab Therapeutics location is at 90 Bridge Street Suite 100
Who are Siamab Therapeutics competitors?
Siamab Therapeutics main competitors are Eureka Therapeutics, Surface Oncology
Who is Siamab Therapeutics leadership?
are part of Siamab Therapeutics leadership, Jeff Behrens is the CEO